✦ LIBER ✦

Studies with iressa, a novel EGF receptor tyrosine kinase inhibitor on breast cancer cells and in situ cancer “in vivo”

✍ Scribed by K.C. Chan; W.F. Knox; N.G. Anderson; T. Ahmed; C.S. Potten; N.J. Bundred

Book ID: 117657625
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 123 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80079-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the EGF receptor in ovarian ca

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)

✍ Sewell, J M; Macleod, K G; Ritchie, A; Smyth, J F; Langdon, S P 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 166 KB

Effects of receptor tyrosine kinase inhi

Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro

✍ Jane M. Turbov; George M. Twaddle; Xiaohe Yang; Naxin M. Liu; Satya Murthy 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

ZD1839 (IRESSA), an EGFR-selective tyros

ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells

✍ Fortunato Ciardiello; Rosa Caputo; Gaetano Borriello; Donatella Del Bufalo; Anna 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 339 KB

## Abstract Constitutive bcl‐2 overexpression increases the tumorigenic and metastatic potential of doxorubicin‐resistant, estrogen‐independent, MCF‐7 ADR human breast cancer cells. We evaluated the sensitivity to taxanes (paclitaxel, docetaxel and IDN 5109) of 2 bcl‐2‐overexpressing MCF‐7 ADR clon

The anti-proliferative effects of tyrosi

The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase

✍ A.A El-Zarruk; H.W van den Berg 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

Absorption of CH330331, a novel 4-anilin

Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models

✍ Haiyan Sun; Huichang Bi; Min Huang; Dong Liu; Zhenyu Qin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views